Human hematopoietic stem cells stimulated to proliferate in vitro lose engraftment potential during their S/G(2)/M transit and do not reenter G(0).

An understanding of mechanisms regulating hematopoietic stem cell engraftment is of pivotal importance to the clinical use of cultured and genetically modified transplants. Human cord blood (CB) cells with lymphomyeloid repopulating activity in NOD/SCID mice were recently shown to undergo multiple self-renewal divisions within 6 days in serum-free cultures containing Flt3-ligand, Steel factor, interleukin 3 (IL-3), IL-6, and granulocyte colony-stimulating factor. The present study shows that, on the fifth day, the transplantable stem cell activity is restricted to the G(1) fraction, even though both colony-forming cells (CFCs) and long-term culture-initiating cells (LTC-ICs) in the same cultures are approximately equally distributed between G(0)/G(1) and S/G(2)/M. Interestingly, the G(0) cells defined by their low levels of Hoechst 33342 and Pyronin Y staining, and reduced Ki67 and cyclin D expression (representing 21% of the cultured CB population) include some mature erythroid CFCs but very few primitive CFCs, LTC-ICs, or repopulating cells. Although these findings suggest a cell cycle-associated change in in vivo stem cell homing, the cultured G(0)/G(1) and S/G(2)/M CD34(+) CB cells exhibited no differences in levels of expression of VLA-4, VLA-5, or CXCR-4. Moreover, further incubation of these cells for 1 day in the presence of a concentration of transforming growth factor beta(1) that increased the G(0)/G(1) fraction did not enhance detection of repopulating cells. The demonstration of a cell cycle-associated mechanism that selectively silences the transplantability of proliferating human hematopoietic stem cells poses both challenges and opportunities for the future improvement of ex vivo-manipulated grafts. (Blood. 2000;96:4185-4193)

[1]  C. Eaves,et al.  During ontogeny primitive (CD34(+)CD38(-)) hematopoietic cells show altered expression of a subset of genes associated with early cytokine and differentiation responses of their adult counterparts. , 2000, Blood.

[2]  C. Eaves,et al.  SDF-1 And tgf-β enhance the detection of transplantable human stem cells regenerating in nod/scid mice , 2000 .

[3]  J. Licht,et al.  Interaction between plzf and eto-a possible link in the molecular mechanisms of M2 and M3 leukemia , 2000 .

[4]  M. Kim,et al.  Modulation of hematopoietic stem/progenitor cell engraftment by transforming growth factor beta. , 2000, Experimental hematology.

[5]  J. Audet,et al.  High-resolution tracking of cell division suggests similar cell cycle kinetics of hematopoietic stem cells stimulated in vitro and in vivo. , 2000, Blood.

[6]  J. Cashman,et al.  Differentiation stage-specific regulation of primitive human hematopoietic progenitor cycling by exogenous and endogenous inhibitors in an in vivo model. , 1999, Blood.

[7]  L. Ailles,et al.  Retroviral marking of acute myelogenous leukemia progenitors that initiate long-term culture and growth in immunodeficient mice. , 1999, Experimental hematology.

[8]  B O Palsson,et al.  Symmetry of initial cell divisions among primitive hematopoietic progenitors is independent of ontogenic age and regulatory molecules. , 1999, Blood.

[9]  C. Eaves,et al.  Direct evidence for multiple self-renewal divisions of human in vivo repopulating hematopoietic cells in short-term culture. , 1999, Blood.

[10]  C. Eaves,et al.  Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia. , 1999, Blood.

[11]  C. Eaves,et al.  Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult marrow. , 1999, Experimental hematology.

[12]  J. Lévesque,et al.  CD44 isoforms in normal and leukemic hematopoiesis. , 1999, Experimental hematology.

[13]  Lesley J. Murray,et al.  CD34+ cells from mobilized peripheral blood retain fetal bone marrow repopulating capacity within the Thy-1+ subset following cell division ex vivo. , 1999, Experimental hematology.

[14]  W. Piacibello,et al.  Engraftment in nonobese diabetic severe combined immunodeficient mice of human CD34(+) cord blood cells after ex vivo expansion: evidence for the amplification and self-renewal of repopulating stem cells. , 1999, Blood.

[15]  C. Eaves,et al.  Optimization of retroviral-mediated gene transfer to human NOD/SCID mouse repopulating cord blood cells through a systematic analysis of protocol variables. , 1999, Experimental hematology.

[16]  R. Alon,et al.  Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. , 1999, Science.

[17]  W. Piacibello,et al.  HEMATOPOIESIS Engraftment in Nonobese Diabetic Severe Combined Immunodeficient Mice of Human CD 34 1 Cord Blood Cells After Ex Vivo Expansion : Evidence for the Amplification and Self-Renewal of Repopulating Stem Cells , 1999 .

[18]  J. Cancelas,et al.  Highly efficient transduction of the green fluorescent protein gene in human umbilical cord blood stem cells capable of cobblestone formation in long-term cultures and multilineage engraftment of immunodeficient mice. , 1998, Blood.

[19]  D. Hogge,et al.  Most acute myeloid leukemia progenitor cells with long-term proliferative ability in vitro and in vivo have the phenotype CD34(+)/CD71(-)/HLA-DR-. , 1998, Blood.

[20]  A. Thrasher,et al.  High efficiency gene transfer to human hematopoietic SCID-repopulating cells under serum-free conditions. , 1998, Blood.

[21]  N. Taylor,et al.  Reduction in levels of the cyclin-dependent kinase inhibitor p27(kip-1) coupled with transforming growth factor beta neutralization induces cell-cycle entry and increases retroviral transduction of primitive human hematopoietic cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[22]  D. Clapp,et al.  Cell cycle-related changes in repopulating capacity of human mobilized peripheral blood CD34(+) cells in non-obese diabetic/severe combined immune-deficient mice. , 1998, Blood.

[23]  P. Lansdorp,et al.  Asymmetric Cell Divisions Sustain Long-Term Hematopoiesis from Single-sorted Human Fetal Liver Cells , 1998, The Journal of experimental medicine.

[24]  D. McMillin,et al.  VLA-5 is expressed by mouse and human long-term repopulating hematopoietic cells and mediates adhesion to extracellular matrix protein fibronectin. , 1998, The Journal of clinical investigation.

[25]  C. Eaves,et al.  Differences between normal and cml stem cells: Potential targets for clinical exploitation , 1998, Stem cells.

[26]  M. Yamaguchi,et al.  Different adhesive characteristics and VLA-4 expression of CD34(+) progenitors in G0/G1 versus S+G2/M phases of the cell cycle. , 1998, Blood.

[27]  J. Mary,et al.  Role of adhesion molecules in the homing and mobilization of murine hematopoietic stem and progenitor cells. , 1998, Blood.

[28]  J. Wuu,et al.  The Fluctuating Phenotype of the Lymphohematopoietic Stem Cell with Cell Cycle Transit , 1998, The Journal of experimental medicine.

[29]  L. Kanz,et al.  Ex vivo expansion of hematopoietic progenitor cells for clinical use. , 1998, Seminars in hematology.

[30]  M. J.,et al.  Ontogeny‐associated changes in the cytokine responses of primitive human haemopoietic cells , 1998, British journal of haematology.

[31]  F. Prósper,et al.  Mobilization and homing of peripheral blood progenitors is related to reversible downregulation of alpha4 beta1 integrin expression and function. , 1998, The Journal of clinical investigation.

[32]  J. Nolta,et al.  Engraftment and retroviral marking of CD34+ and CD34+CD38- human hematopoietic progenitors assessed in immune-deficient mice. , 1998, Blood.

[33]  C. Eaves,et al.  Efficient retroviral-mediated gene transfer to human cord blood stem cells with in vivo repopulating potential. , 1998, Blood.

[34]  R. Pyatt,et al.  Functional Heterogeneity of Human CD34+ Cells Isolated in Subcompartments of the G0 /G1 Phase of the Cell Cycle , 1997 .

[35]  C. Schmoor,et al.  Transforming growth factor‐beta 1 delays formation of granulocyte‐macrophage colony‐forming cells, but spares more primitive progenitors during ex vivo expansion of CD34+ haemopoietic progenitor cells , 1997, British journal of haematology.

[36]  M. Cazzola,et al.  Both cycling and noncycling primitive progenitors continue to be mobilized into the circulation during the leukapheresis of patients pretreated with chemotherapy and G‐CSF , 1997, British journal of haematology.

[37]  P J Quesenberry,et al.  Cell cycle analysis and synchronization of pluripotent hematopoietic progenitor stem cells. , 1997, Blood.

[38]  C. Eaves,et al.  Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[39]  C. Eaves,et al.  High‐resolution cell division tracking demonstrates the Flt3‐ligand‐dependence of human marrow CD34+CD38− cell production in vitro , 1997, British journal of haematology.

[40]  J. Dick,et al.  Quantitative Analysis Reveals Expansion of Human Hematopoietic Repopulating Cells After Short-term Ex Vivo Culture , 1997, The Journal of experimental medicine.

[41]  J. Dick,et al.  Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell , 1997, Nature Medicine.

[42]  J. Dick,et al.  Kinetic evidence of the regeneration of multilineage hematopoiesis from primitive cells in normal human bone marrow transplanted into immunodeficient mice. , 1997, Blood.

[43]  P. Lansdorp,et al.  Lack of expression of Thy-1 (CD90) on acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo. , 1997, Blood.

[44]  R. Pyatt,et al.  Functional heterogeneity of human CD34(+) cells isolated in subcompartments of the G0 /G1 phase of the cell cycle. , 1997, Blood.

[45]  David A. Williams,et al.  Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy , 1996, Nature Medicine.

[46]  C. Eaves,et al.  Enhanced detection, maintenance, and differentiation of primitive human hematopoietic cells in cultures containing murine fibroblasts engineered to produce human steel factor, interleukin-3, and granulocyte colony-stimulating factor. , 1996, Blood.

[47]  G. Wagemaker,et al.  Fluorouracil selectively spares acute myeloid leukemia cells with long-term growth abilities in immunodeficient mice and in culture. , 1996, Blood.

[48]  F. Prósper,et al.  Phenotypic and functional characterization of long-term culture-initiating cells present in peripheral blood progenitor collections of normal donors treated with granulocyte colony-stimulating factor. , 1996, Blood.

[49]  C. Hannum,et al.  Flt3 ligand induces proliferation of quiescent human bone marrow CD34+CD38- cells and maintains progenitor cells in vitro. , 1996, Blood.

[50]  P. Quesenberry,et al.  Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL-6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts. , 1996, Blood.

[51]  C. Eaves,et al.  Quantitation of the quiescent fraction of long-term culture-initiating cells in normal human blood and marrow and the kinetics of their growth factor-stimulated entry into S-phase in vitro. , 1995, Blood.

[52]  C. Craddock,et al.  The VLA4/VCAM-1 adhesion pathway defines contrasting mechanisms of lodgement of transplanted murine hemopoietic progenitors between bone marrow and spleen. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[53]  M. Vadas,et al.  Cytokines increase human hemopoietic cell adhesiveness by activation of very late antigen (VLA)-4 and VLA-5 integrins , 1995, The Journal of experimental medicine.

[54]  S. Kosak,et al.  Evaluation of ex vivo expansion potential of cord blood and bone marrow hematopoietic progenitor cells using cell tracking and limiting dilution analysis. , 1995, Blood.

[55]  C. Craddock,et al.  VLA4/VCAM‐1接着経路が骨髄とひ臓の間で移植したマウス造血幹細胞の対照的な定着機構を決定する , 1995 .

[56]  V. Broudy,et al.  Stem cell factor modulates avidity of alpha 4 beta 1 and alpha 5 beta 1 integrins expressed on hematopoietic cell lines. , 1995, Blood.

[57]  G. Sauvageau,et al.  Differential expression of homeobox genes in functionally distinct CD34+ subpopulations of human bone marrow cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[58]  S. Nishikawa,et al.  Involvement of the c-kit receptor in the adhesion of hematopoietic stem cells to stromal cells. , 1994, Experimental hematology.

[59]  D. Kohn,et al.  Sustained human hematopoiesis in immunodeficient mice by cotransplantation of marrow stroma expressing human interleukin-3: analysis of gene transduction of long-lived progenitors. , 1994, Blood.

[60]  A. Flake,et al.  Long-term repopulating ability of xenogeneic transplanted human fetal liver hematopoietic stem cells in sheep. , 1994, The Journal of clinical investigation.

[61]  H. Broxmeyer,et al.  Comparative effects of suppressive cytokines on isolated single CD34(3+) stem/progenitor cells from human bone marrow and umbilical cord blood plated with and without serum. , 1993, Experimental hematology.

[62]  I. Weissman,et al.  Functional heterogeneity is associated with the cell cycle status of murine hematopoietic stem cells , 1993, The Journal of cell biology.

[63]  P. Brown,et al.  Integration of murine leukemia virus DNA depends on mitosis. , 1993, The EMBO journal.

[64]  J. Hatzfeld,et al.  Release of early human hematopoietic progenitors from quiescence by antisense transforming growth factor beta 1 or Rb oligonucleotides , 1991, The Journal of experimental medicine.

[65]  David A. Williams,et al.  Fibronectin and VLA-4 in haematopoietic stem cell–microenvironment interactions , 1991, Nature.

[66]  A. Miller,et al.  Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection , 1990, Molecular and cellular biology.

[67]  C. Eaves,et al.  Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[68]  C. Eaves,et al.  Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. I. Stimulatory role of a variety of mesenchymal cell activators and inhibitory role of TGF-beta. , 1990, Blood.

[69]  J. Dick,et al.  Engraftment of immune-deficient mice with human hematopoietic stem cells. , 1988, Science.

[70]  F. Ruscetti,et al.  Transforming growth factor beta selectively inhibits normal and leukemic human bone marrow cell growth in vitro. , 1988, Blood.

[71]  J. Unkeless.  Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors , 1979, The Journal of experimental medicine.